Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosis.

Literature DB >> 21048798

Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosis.

Anne H Cross, Gregory F Wu.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2010 PMID： 21048798 DOI： 10.1038/nrneurol.2010.142

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

× No keyword cloud information.

10 in total

1. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair.

Authors: M Mateo Paz Soldán; Arthur E Warrington; Allan J Bieber; Bogoljub Ciric; Virginia Van Keulen; Larry R Pease; Moses Rodriguez
Journal: Mol Cell Neurosci Date: 2003-01 Impact factor: 4.314

2. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta.

Authors: M Lundkvist; E Greiner; J Hillert; A Fogdell-Hahn
Journal: Mult Scler Date: 2010-06-09 Impact factor: 6.312

3. Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.

Authors: I Bosca; L M Villar; F Coret; M J Magraner; M Simó-Castelló; J C Alvarez-Cermeño; B Casanova
Journal: Mult Scler Date: 2010-06-10 Impact factor: 6.312

4. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

Authors: Amit Bar-Or; Lama Fawaz; Boli Fan; Peter J Darlington; Aja Rieger; Christine Ghorayeb; Peter A Calabresi; Emmanuelle Waubant; Stephen L Hauser; Jiameng Zhang; Craig H Smith
Journal: Ann Neurol Date: 2010-04 Impact factor: 10.422

5. Oligoclonal band number as a marker for prognosis in multiple sclerosis.

Authors: J R Avasarala; A H Cross; J L Trotter
Journal: Arch Neurol Date: 2001-12

6. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.

Authors: Laura Piccio; Robert T Naismith; Kathryn Trinkaus; Robyn S Klein; Becky J Parks; Jeri A Lyons; Anne H Cross
Journal: Arch Neurol Date: 2010-06

7. Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment.

Authors: N García-Barragán; L M Villar; M Espiño; M C Sádaba; P González-Porqué; J C Alvarez-Cermeño
Journal: Eur J Neurol Date: 2009-03 Impact factor: 6.089

8. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.

Authors: F G Joseph; C L Hirst; T P Pickersgill; Y Ben-Shlomo; N P Robertson; N J Scolding
Journal: J Neurol Neurosurg Psychiatry Date: 2008-10-01 Impact factor: 10.154

9. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors: Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal: N Engl J Med Date: 2008-02-14 Impact factor: 91.245

10. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.

Authors: Gregory P Owens; Jeffrey L Bennett; Hans Lassmann; Kevin C O'Connor; Alanna M Ritchie; Andrew Shearer; Chiwah Lam; Xiaoli Yu; Marius Birlea; Cecily DuPree; R Anthony Williamson; David A Hafler; Mark P Burgoon; Don Gilden
Journal: Ann Neurol Date: 2009-06 Impact factor: 10.422

10 in total

Review 1. Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Authors: Bharath Wootla; Jens O Watzlawik; Nikolaos Stavropoulos; Nathan J Wittenberg; Harika Dasari; Murtada A Abdelrahim; John R Henley; Sang-Hyun Oh; Arthur E Warrington; Moses Rodriguez
Journal: Expert Opin Biol Ther Date: 2016-03-10 Impact factor: 4.388

Review 2. Distinguishing Susac's syndrome from multiple sclerosis.

Authors: Katherine A Buzzard; Stephen W Reddel; Con Yiannikas; D Sean Riminton; Michael H Barnett; Todd A Hardy
Journal: J Neurol Date: 2014-12-30 Impact factor: 4.849

Review 3. Characteristics of Susac syndrome: a review of all reported cases.

Authors: Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal: Nat Rev Neurol Date: 2013-04-30 Impact factor: 42.937

Review 4. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors: Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal: Expert Rev Clin Immunol Date: 2014-12-18 Impact factor: 4.473

5. Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis.

Authors: Kathryn M Brennan; Francesc Galban-Horcajo; Simon Rinaldi; Colin P O'Leary; Carl S Goodyear; Gabriela Kalna; Ariel Arthur; Christina Elliot; Sue Barnett; Christopher Linington; Jeffrey L Bennett; Gregory P Owens; Hugh J Willison
Journal: J Neuroimmunol Date: 2011-08-26 Impact factor: 3.478